For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Fundacio Institut De Recerca Biomedica (irb Barcelona)

USPTO Granted Patents = 12

EPO Patents = 19

Forward Citations = 68

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Roger Gomis (7 out of 19 patents)

Maria Tarragona (5 out of 7 patents)

Anna Arnal (5 out of 7 patents)

4. Milica Pavlovic (5 out of 7 patents)

5. Evarist Planet (4 out of 6 patents)

6. Ernest Giralt Lledó (2 out of 5 patents)

7. Roger Prades Cosano (2 out of 5 patents)

8. Salvador Aznar Benitah (2 out of 2 patents)

9. Gloria Pascual Angulo (2 out of 2 patents)

10. Andres Castellanos Martin (2 out of 2 patents)

11. Merce Martin Peña (2 out of 2 patents)

12. Miriam Royo Expósito (1 out of 3 patents)

13. Fernando Albericio Palomera (1 out of 6 patents)

14. Antonio Pedro Villaverde Corrales (1 out of 7 patents)

15. Teresa Tarragó Clua (1 out of 3 patents)

12 patents: Sort by Forward Citations

1. 12312642 - Method for the diagnosis, prognosis and treatment of breast cancer metastasis (2025-05-27),

2. 12286484 - Targeting metastasis stem cells through a fatty acid receptor (CD36) (2025-04-29),

3. 11591599 - Method for the diagnosis, prognosis and treatment of cancer metastasis (2023-02-28),

4. 11535680 - Targeting metastasis stem cells through a fatty acid receptor (CD36) (2022-12-27),

5. 11352673 - Method for the diagnosis, prognosis and treatment of lung cancer metastasis (2022-06-07),

6. 11072831 - Method for the diagnosis, prognosis and treatment of breast cancer metastasis (2021-07-27),

7. 10866241 - Method for the prognosis and treatment of cancer metastasis (2020-12-15),

8. 10125097 - 1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives (2018-11-13),

9. 10047398 - Method for the diagnosis, prognosis and treatment of breast cancer metastasis (2018-08-14),

10. 10006091 - Method for the diagnosis, prognosis and treatment of lung cancer metastasis (2018-06-26),

11. 9744247 - Functionalized liposomes useful for the delivery of bioactive compounds (2017-08-29),

12. 9475840 - Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs (2016-10-25),

Founded in 2005, Fundació Institut de Recerca Biomedica (IRB Barcelona) is a leading biomedical research center in Spain. The institute focuses on understanding fundamental molecular processes and their alterations in the development of diseases, with the ultimate goal of developing new treatments. IRB Barcelona conducts cutting-edge research in fields such as cancer, neurodegenerative diseases, and diabetes, and collaborates with international researchers and institutions to accelerate scientific discoveries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#50 in

#170 in

#46,665 in the World

Barcelona, Spain

Fundacio Institut De Recerca Biomedica (irb Barcelona)

Forward Citations = 68

25 inventors:

Roger Gomis (7 out of 19 patents)

Maria Tarragona (5 out of 7 patents)

Anna Arnal (5 out of 7 patents)

4. Milica Pavlovic (5 out of 7 patents)

5. Evarist Planet (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…